Hellokitty
Diamond Member
- Oct 12, 2009
- 10,047
- 10,175
- 2,185
AI Overview
While serious adverse effects from COVID-19 vaccines are
rare, there has been a discussion and research around certain adverse events (AEs) that have been reported, and some concerns regarding how they could potentially be mitigated or better addressed in the future.
Serious but Rare AEs and Potential Mitigation:
General Considerations for Mitigation and Prevention:
- Myocarditis and Pericarditis:
- Description: Inflammation of the heart muscle (myocarditis) or the lining around the heart (pericarditis), which has been linked to mRNA COVID-19 vaccines. It is most frequent in adolescent and young adult males after the second dose.
- Mitigation Efforts: Information on the rare risk of myocarditis and pericarditis following vaccination is now shared with individuals, especially males ages 12-39. Extending the interval between the first and second dose might reduce the risk in some people. Those who develop myocarditis or pericarditis after a vaccine dose are generally advised not to receive a subsequent dose.
- Thrombosis with Thrombocytopenia Syndrome (TTS):
- Description: A rare but serious clotting disorder associated with the Janssen COVID-19 vaccine, involving blood clots and low platelet counts.
- Mitigation Efforts: After observing this rare but serious AE, the Advisory Committee on Immunization Practices (ACIP) recommended using mRNA vaccines (Pfizer-BioNTech and Moderna) instead of the J&J/Janssen vaccine.
- Guillain-Barré Syndrome (GBS):
- Description: A rare neurological disorder where the immune system attacks nerves, causing muscle weakness and potentially paralysis. It was linked to the J&J/Janssen COVID-19 vaccine at a higher rate than with mRNA vaccines.
- Mitigation Efforts: Similar to TTS, the ACIP recommended mRNA vaccines as the preferred option due to the higher rate of GBS associated with the J&J/Janssen vaccine.
- Anaphylaxis:
- Description: A severe allergic reaction that can occur after any vaccine, although it's rare with COVID-19 vaccines.
- Mitigation Efforts: Healthcare providers are trained to recognize and treat anaphylaxis immediately. Individuals with a history of severe allergic reactions to a vaccine ingredient should avoid that vaccine type.
- Shoulder Injuries Related to Vaccine Administration (SIRVA):
- Description: Injury to the shoulder caused by the injection of the vaccine.
- Mitigation: While not specific to COVID-19 vaccines, proper injection technique and careful administration can prevent SIRVA.
Important Notes:
- Open and Transparent Communication: Providing accurate information about vaccine side effects and safety data to the public is important for building trust and addressing concerns.
- Post-Marketing Surveillance: Systems like VAERS are crucial for monitoring vaccine safety and identifying any potential issues that were not apparent in clinical trials.
- Understanding Underlying Mechanisms: Research into the potential biological mechanisms underlying rare adverse events, such as the role of the spike protein or vaccine components, could lead to better treatment options and potentially vaccine modifications in the future.
- Addressing Vaccine Hesitancy: Strategies to address vaccine hesitancy and increase vaccine confidence, including accurate information dissemination and addressing individual concerns, can help improve vaccine uptake and public health outcomes.
- The vast majority of COVID-19 vaccine side effects are mild and resolve quickly.
- The benefits of COVID-19 vaccination, such as preventing severe illness, hospitalization, and death, significantly outweigh the rare risks of serious adverse events.
- Continued research and monitoring are necessary to assess the long-term effects of vaccines and address any new safety concerns that may arise.
Sorry but releasing such important medical disclosers long after promoting the COVID vac as safe for babies/children/teens/young adults should be criminal, these people are luck to only get fired!!!